Search Tag: Hologic

IMAGING Management

Hologic selected for Dutch Breast Cancer Screening Program

2017 02 Nov

Under the tender, state-of-the-art 3DimensionsTM mammography systems will be installed starting in 2018   Hologic, Inc. (Nasdaq: HOLX) has announced that it will provide all mammography systems for the Dutch Breast Cancer Screening Program in partnership with Tromp Medical, Hologic’s distributor in the Netherlands. Under the tender, Hologic’s new, state-of-the-art... Read more

IMAGING Management

2017 30 Oct

Expanding leadership based on clinical evidence In early September, Hologic launched the new 3Dimensions™ mammography system, a breast tomosynthesis system with the fastest and highest resolution, in EMEA. I recently had the pleasure of showcasing this cutting-edge device at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting,... Read more

IMAGING Management

Paraflu Assay Now FDA Cleared on Hologic's New Panther Fusion® System

2017 26 Oct

-- New Assay Extends Respiratory Testing Menu; Modular Panels and Fusion System Increase Efficiency and Flexibility for the Laboratory –   Hologic, Inc. (Nasdaq: HOLX) announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Paraflu assay, a multiplexed assay which runs on the... Read more

IMAGING Management

Hologic Receives CE Mark to Market SculpSure® for Non-Invasive Body Contouring of the Submental Area

2017 19 Oct

Patients in Clinical Studies Report 100% Satisfaction Hologic, Inc. (Nasdaq: HOLX) has announced that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser treatment. The device is now certified to treat a double chin (also known as the submental area), marking the... Read more

IMAGING Management

Panther Fusion® Flu A/B/RSV Assay Now FDA Cleared on Hologic's New Panther Fusion® System

2017 06 Oct

- New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory   Hologic, Inc. (Nasdaq: HOLX) has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Flu A/B/RSV assay running on the new Panther Fusion®... Read more

IMAGING Management

Hologic enters into amended and restated five-year secured credit agreement

2017 04 Oct

- Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt -- Funds Also Expected to Contribute to Retirement of Remaining Convertible Notes -Hologic, Inc. (NASDAQ: HOLX) has announced  that the Company has entered into an amended and restated credit agreement consisting of a new,... Read more

IMAGING Management

Hologic announces offering of $350 Million of Senior Notes due 2025

2017 04 Oct

- Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes -Hologic, Inc. (NASDAQ: HOLX) has announced that it has launched, subject to market and other conditions, a private offering of $350 million aggregate principal amount of senior notes due 2025.  Hologic intends to use the proceeds of the offering and available cash, including... Read more

IMAGING Management

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2017

2017 03 Oct

Hologic, Inc. (Nasdaq: HOLX) has announced that the Company plans to release its financial results for the fourth quarter of fiscal 2017 on Wednesday, November 8, 2017 after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.   Interested participants may listen to the call... Read more

IMAGING Management

Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell to Kick Off Breast Cancer Awareness Month

2017 30 Sep

Trailblazing Company Behind the Genius™ 3D Mammography™ Exam Celebrates Year of Innovations in Breast Health Hologic, Inc. (Nasdaq: HOLX) has announced that Steve MacMillan, the Company's Chairman, President and Chief Executive Officer, will join selected employees to ring the Nasdaq Opening Bell on October 2 in conjunction with the start of Breast... Read more

IMAGING Management

Hologic receives FDA 510(k) clearance to market SculpSure® for non-invasive body contouring

2017 30 Sep

Patients in Clinical Studies Report 100% Satisfaction Rate   Hologic, Inc. (Nasdaq: HOLX) has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product, SculpSure®. The state-of-the-art body contouring laser treatment is now cleared to treat a double chin... Read more